These TFs with highly debatable involvement in HCC progression came to light as possibly further serving as intermediates of RANBP2 and HCC progression, precisely because RANBP2 is a nuclear protein normally excluded from the cytoplasm by the nuclear pore complex (NPC) [23]. Here, RANBP2 is linked to hepatocellular carcinoma.